Health Care Innovation
Business & Economics
New Medicare Price Controls Don’t Put America First
Health and Human Services Secretary Alex Azar just released a sweeping proposal that would drastically change how Medicare pays for advanced cancer therapies and other potent medicines. The plan relies on foreign price controls to reduce drug spending by $17 billion over five years. Although drug spending may decline, as ...
Commentary
Medicare Advantage’s Popularity Shows Americans Won’t Like Single-Payer
Democrats hope their advocacy of single-payer health care will help them in the upcoming midterm elections. More than half the Democrats running for seats in the House back Medicare for All. It remains to be seen if their embrace of government-run health care, where private coverage is banned for anything ...
Blog
Does President Trump Favor Price Controls?
At 2 pm Eastern time today, President Trump spoke at the Department of Health and Human Services where he recommended a litany of policies that would ultimately impose price controls on the pharmaceutical market. Take his proposal to force the prices paid by Medicare for drugs administer in doctors’ offices ...
Business & Economics
Repeal the Medical Device Tax
Rarely is there bipartisan agreement that a tax cut won’t cost the federal government money. But, in the case of the medical device tax (a 2.3 percent tax on medical devices and products that was passed as part of the Affordable Care Act) this is true by definition because the ...
Business & Economics
The benefits of repealing the medical device tax
As part of the Affordable Care Act, a 2.3 percent tax on medical devices and products was passed. The tax was levied on devices such as pacemakers, advanced imaging technologies (Cat Scan, MRI and ultrasound equipment), artificial joints, surgical gloves, and dental instruments. Devices that the public generally buys for ...
Health Care
New PRI Study: Congress Has Some Unfinished Business – Acting to Repeal the Medical Device Tax
The controversial medical device tax hurts doctors, patients and manufacturers and should be repealed by Congress – according a new study released today by the California-based, free-market think tank, the Pacific Research Institute. Click here to download a copy of the study. “As the congressional session winds down, Congress has ...
Agriculture
Nationally-Renowned Scholar Henry Miller, M.S., M.D., Joins Pacific Research Institute as Senior Fellow in Health Care
Former Hoover Fellow’s Research Will Focus on Genetic Engineering, Evidence-Based Medicine, Regulatory Reform SAN FRANCISCO – The Pacific Research Institute, California’s leading free-market think tank, today announced the hiring of nationally-renowned scholar and researcher and former Hoover Institution fellow Dr. Henry Miller as a Senior Fellow in Health Care. At ...
Commentary
Obamacare’s Risk Adjustment Payments Should Have Stayed Frozen
In early July, the Trump administration announced that it would suspend $10 billion in transfer payments to insurers after a federal court ruled that Obamacare’s “risk-adjustment” program was flawed. The program authorizes the federal government to take money from exchange insurers with an above-average share of healthy enrollees and redistribute ...
Commentary
California’s Costly, Inaccessible Healthcare System
More than one-third of California’s $200 billion budget goes toward health care. Private health insurance spending in the state, meanwhile, exceeds more than $100 billion a year. Unfortunately, all that spending doesn’t appear to make health care more accessible. That’s the troubling finding of a comprehensive new analysis of health ...
Business & Economics
It’s Generics Not PBMs That Keep Pharmaceuticals Affordable
Expenditures on prescription drugs grew 12.4 percent in 2014 and 8.9 percent in 2015. These eye-popping data are not representative of the long-term expenditure trend, however. Not only did the growth in prescription drugs expenditures slow to 1.3 percent in 2016, longer-term (between 2009 and 2016), the average annual growth ...
New Medicare Price Controls Don’t Put America First
Health and Human Services Secretary Alex Azar just released a sweeping proposal that would drastically change how Medicare pays for advanced cancer therapies and other potent medicines. The plan relies on foreign price controls to reduce drug spending by $17 billion over five years. Although drug spending may decline, as ...
Medicare Advantage’s Popularity Shows Americans Won’t Like Single-Payer
Democrats hope their advocacy of single-payer health care will help them in the upcoming midterm elections. More than half the Democrats running for seats in the House back Medicare for All. It remains to be seen if their embrace of government-run health care, where private coverage is banned for anything ...
Does President Trump Favor Price Controls?
At 2 pm Eastern time today, President Trump spoke at the Department of Health and Human Services where he recommended a litany of policies that would ultimately impose price controls on the pharmaceutical market. Take his proposal to force the prices paid by Medicare for drugs administer in doctors’ offices ...
Repeal the Medical Device Tax
Rarely is there bipartisan agreement that a tax cut won’t cost the federal government money. But, in the case of the medical device tax (a 2.3 percent tax on medical devices and products that was passed as part of the Affordable Care Act) this is true by definition because the ...
The benefits of repealing the medical device tax
As part of the Affordable Care Act, a 2.3 percent tax on medical devices and products was passed. The tax was levied on devices such as pacemakers, advanced imaging technologies (Cat Scan, MRI and ultrasound equipment), artificial joints, surgical gloves, and dental instruments. Devices that the public generally buys for ...
New PRI Study: Congress Has Some Unfinished Business – Acting to Repeal the Medical Device Tax
The controversial medical device tax hurts doctors, patients and manufacturers and should be repealed by Congress – according a new study released today by the California-based, free-market think tank, the Pacific Research Institute. Click here to download a copy of the study. “As the congressional session winds down, Congress has ...
Nationally-Renowned Scholar Henry Miller, M.S., M.D., Joins Pacific Research Institute as Senior Fellow in Health Care
Former Hoover Fellow’s Research Will Focus on Genetic Engineering, Evidence-Based Medicine, Regulatory Reform SAN FRANCISCO – The Pacific Research Institute, California’s leading free-market think tank, today announced the hiring of nationally-renowned scholar and researcher and former Hoover Institution fellow Dr. Henry Miller as a Senior Fellow in Health Care. At ...
Obamacare’s Risk Adjustment Payments Should Have Stayed Frozen
In early July, the Trump administration announced that it would suspend $10 billion in transfer payments to insurers after a federal court ruled that Obamacare’s “risk-adjustment” program was flawed. The program authorizes the federal government to take money from exchange insurers with an above-average share of healthy enrollees and redistribute ...
California’s Costly, Inaccessible Healthcare System
More than one-third of California’s $200 billion budget goes toward health care. Private health insurance spending in the state, meanwhile, exceeds more than $100 billion a year. Unfortunately, all that spending doesn’t appear to make health care more accessible. That’s the troubling finding of a comprehensive new analysis of health ...
It’s Generics Not PBMs That Keep Pharmaceuticals Affordable
Expenditures on prescription drugs grew 12.4 percent in 2014 and 8.9 percent in 2015. These eye-popping data are not representative of the long-term expenditure trend, however. Not only did the growth in prescription drugs expenditures slow to 1.3 percent in 2016, longer-term (between 2009 and 2016), the average annual growth ...
